International Patent: RECOMBINANT ADENO-ASSOCIATED VIRUS VECTOR FOR DELIVERING HUMAN C3B SINGLE-DOMAIN ANTIBODY OR FUSION PROTEIN THEREOF

GENEVA, Oct. 9 -- SUZHOU TOPCLONE PHARMACEUTICAL TECHNOLOGY COMPANY LTD. filed a patent application (CN2026/087989) for “RECOMBINANT ADENO-ASSOCIATED VIRUS VECTOR FOR DELIVERING HUMAN C3B SINGLE-DOMAIN ANTIBODY OR FUSION PROTEIN THEREOF”. With publication no. WO/2026/208942, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 15/864

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....